Variables | N | Surgical exploration N = 29 | Palliative group N = 87 | P-value |
Age | 116 | 67 (63 - 77) | 72 (64 - 79) | 0.165 |
Female gender | 116 | 17 (58.6%) | 45 (51.7%) | 0.519 |
Tumor size (cm) | 116 | 3 (2 - 4) | 3 (2 - 4) | 0.658 |
Presence of metastases | 116 | 6 (20.7%) | 23 (26.4%) | 0.626 |
WBC >10 × 109/L | 113 | 3 (10.3) | 18 (21.4) | 0.270 |
CRP >5 mg/L | 112 | 12 (41.4%) | 62 (74.7%) | 0.001 |
Palliative chemotherapy | 114 | 24 (82.8%) | 58 (68.2%) | 0.133 |
Time to chemotherapy (months)* |
| 2 (1 - 2) | 1 (0.7 - 1) | <0.001 |
No. of cycles* |
| 6 (3 - 9) | 5 (3 - 6) | 0.377 |